(Q30417007)

English

Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1. (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Jordan J Elm

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

NINDS NET-PD Investigators

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 October 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Movement Disorders

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

27

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1513-1521

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

A double-blind, delayed-start trial of rasagiline in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Using global statistical tests in long-term Parkinson's disease clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Minority enrollment in Parkinson's disease clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Pharmacokinetics of creatine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

A rank-based sample size method for multiple outcomes in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Levodopa and the progression of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Oxidative stress and genetics in the pathogenesis of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Procedures for comparing samples with multiple endpoints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

New insights into the cause of Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

20 June 2018

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Creatine and cyclocreatine attenuate MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Creatine supplementation and exercise performance: an update

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Assessment of cognition in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Normative Symbol Digit Modalities Test performance in a community-based sample.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.25175

21 January 2018

Levodopa response in early Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3481179

26 November 2018

The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Creatine: a review of its nutritional applications in sport

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications of the 5-year CR FIRST trial. Sinemet CR Five-Year International Response Fluctuation Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/Levodopa Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23079770

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/MDS.25175

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30417007&oldid=1549630619"